Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |